Pharmaceutical Drugs And Biologics MGR 2017
- TBRC2089
- Pages: 350
- July 2017
- Total Views:1491
- Region : Global
- The Business Research Company
- Market Research Report

Details
The pharmaceuticals industry develops drugs to diagnose, cure, treat or prevent diseases. Pharmaceutical companies produce both generic and branded drugs for medications. Pharmaceuticals are subjected to various laws and regulations that deal with patenting, testing, safety, efficacy and marketing of drugs.
Pharmaceutical companies produce biological products, pharmaceutical preparations and medicinal and botanical products.
The global pharmaceutical market is expected to reach over $1300 billion in 2020. one of the key drivers of the pharmaceuticals market during 2016-2020 is expected to include 'New Methods For Drug Discovery'. Stem cells and organ on chip technologies are changing the way drug trials are being conducted. Organ on chips are micro-engineered biometric systems that simulates activities, mechanics and physiological response of organ systems. Drug trial processes such as target identification, validation, target based screening and phenotypic screening are being done through organ on chip and stem cell technologies. These technologies are considerably reducing the drug discovery costs and generating reliable predictions on drug efficiency and human safety. Therefore, low drug discovery costs and accurate results generated from these technologies is expected to drive the pharmaceuticals market.
The Americas was the largest region in the pharmaceutical market in 2016, accounting for around 45% market share. Asia was the second largest region accounting for around 27% market share. Europe was the third largest region accounting for around 22% market share.
One of the top trends that is observed in the pharmaceuticals market include 'Turning Away From Animal Testing'. The pharmaceutical industry is moving away from animal testing towards cheaper and more efficient technologies. For example, LiverChip technology created an alternative model of testing which uses a 3D cell culture platform that mimics the architecture and physiology of a human being, which was significantly less expensive and more efficient than animal testing.
The Pharmaceutical Drugs And Biologics Market Global Report provides strategists, marketers and senior management with the critical information they need to assess the global pharmaceutical drugs and biologics sector.
Reasons to Purchase
Outperform competitors using accurate up to date demand-side dynamics information.
Identify growth segments for investment.
Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
Create regional and country strategies on the basis of local data and analysis.
Stay abreast of the latest customer and market research findings
Benchmark performance against key competitors.
Develop strategies based on likely future developments.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Gain a global perspective on the development of the market.
Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:
Where is the largest and fastest growing market for the pharmaceutical drugs and biologics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical drugs and biologics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider healthcare market, and compares it with other markets.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
Market segmentations break down market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
The pharmaceutical drugs and biologics market section of the report gives context. It compares the pharmaceutical drugs and biologics market with other segments of the healthcare market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Pharmaceutical Drugs And Biologics Indicators Comparison.
The industry metrics section looks at critical drivers including patient numbers (epidemiology) hospital beds and specialist physicians while the macro-economic section looks at the market in relation to the overall economy.
Scope
Markets Covered: Pharmaceuticals, Biologics, Pharmaceutical Drugs
Companies Mentioned: Pfizer, Roche, Glaxosmithkline, Merck & Co., and Sanofi
Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.
Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa
Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Pharmaceutical Drugs And Biologics Indicators Comparison.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Table Of Content
Scope
1. Pharmaceutical Drugs And Biologics Market Characteristics;
2. Pharmaceutical Drugs And Biologics Market Size And Growth;
2.1. Historic Market Growth; 2.1.1. Drivers Of The Market; Aging Populations; Emerging Markets Growth; Health Insurance Reforms; 2.1.2. Restraints On The Market; Patent Expiration Of Drugs; Pricing Pressures From Regulators; High Costs Of Drug Approval; 2.2. Forecast Market Growth; 2.2.1. Drivers Of The Market; Economic Growth; Technology; Changes In Lifestyles; New Methods For Drug Discovery; 2.2.2. Restraints On The Market; Cost; Interest Rate Increases; Reduction In Free Trade;
3. Pestle Analysis;
3.1. Political; 3.2. Economic; 3.3. Social; 3.4. Technological; 3.5. Legal; 3.6. Environmental;
4. Pharmaceutical Drugs And Biologics Market Customer Information;
5. Pharmaceutical Drugs And Biologics Market Segmentation;
5.1. Global Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 5.2. Global Pharmaceutical Drugs And Biologics Market, 2012-2020, Historic And Forecast, By Segment; 5.3 Global Pharmaceutical Drugs And Biologics Market Trends And Strategies; Turning Away From Animal Testing; Increase In Personalized Medicine; Collaboration Driving Innovation; Increase In Mergers And Acquisitions; Rise Of Biologics/Gene Therapy; Aggressive Pricing Changes In Some Drugs; 5.4 Global Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2016; 5.5 Global Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2012-2020, Historic and Forecast; 5.6 Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2016, By Region; 5.7 Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2016, By Country; 5.8 Pharmaceutical Drugs; 5.8.1. Market Characteristics; 5.8.2. Global Pharmaceutical Drugs Market, 2016, By Segment; 5.8.3. Global Pharmaceutical Drugs Market, 2012-2020, Historic and Forecast, By Segment; 5.8.4. Market Trends And Strategies; 5.9 Biologics; 5.9.1. Market Characteristics; 5.9.2. Global Biologics Market, 2016, By Segment; 5.9.3. Global Biologics Market, 2012-2020, Historic and Forecast, By Segment; 5.9.4. Market Trends And Strategies;
6. Pharmaceutical Drugs And Biologics Market Regional And Country Analysis;
6.1. Global Pharmaceutical Drugs And Biologics Market, 2016, By Region; 6.2. Global Pharmaceutical Drugs And Biologics Market, 2012-2020, Historic And Forecast, By Region; 6.3. Pharmaceutical Drugs And Biologics Market, 2016, By Country; 6.4. Pharmaceutical Drugs And Biologics Market, 2012-2020, Historic And Forecast, By Country; 6.5. Global Healthcare Market Segments, 2016, By Region; 6.6. Global Pharmaceutical Drugs And Biologics Market Segments, 2016, By Region; 6.7. Global Healthcare Market Segments, 2016, By Country; 6.8. Global Pharmaceutical Drugs And Biologics Market Segments, 2016, By Country;
7. Global Pharmaceutical Drugs And Biologics Market Comparison With Macro Economic Factors;
7.1. Pharmaceutical Drugs And Biologics Market Size, Percentage Of GDP, Global; 7.2. Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, Global;
8. Pharmaceutical Drugs And Biologics Market Comparison With Macro Economic Factors Across Countries;
8.1. Pharmaceutical Drugs And Biologics Market Size, Percentage Of GDP, By Country; 8.2. Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, By Country;
9. Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics;
9.1. Global Number Of Pharmacists, 2016, By Country; 9.2. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Pharmacists, 2016, By Country; 9.3. Global Number Of Pharma Enterprises, 2016, By Country; 9.4. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country; 9.5. Global Number Of Employees In Pharmaceutical Industry, 2016, By Country; 9.6. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Employees In Pharmaceutical Industry, 2016, By Country; 9.7. Global Average Spending On R&D/Product Development, 2016, By Country; 9.8. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country; 9.9. Global Generic & Branded Sales Proportion By Country (Volume), 2016, By Country; 9.10. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2016, By Country; 9.11. Global Number Of Pharmacies, 2016, By Country; 9.12. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Pharmacies, 2016, By Country; 9.13. Global New Drug Approvals, 2016, By Country; 9.14. Global Pharmaceutical Drugs And Biologics Market Revenue Versus New Drug Approvals, 2016, By Country; 9.15. Global Number Of General Practitioners 2016, By Country; 9.16. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of General Practitioners, 2016, By Country;
10. Asia-Pacific Pharmaceutical Drugs And Biologics Market;
10.1.1. Asia-Pacific Pharmaceutical Drugs And Biologics Market Overview; 10.1.2. Asia-Pacific Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 10.1.3. Asia-Pacific Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 10.1.4. Asia-Pacific Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 10.2. Asia-Pacific Pharmaceutical Drugs And Biologics Market: Country Analysis; 10.3. China Pharmaceutical Drugs And Biologics Market; 10.3.1. China Pharmaceutical Drugs And Biologics Market Overview; Average Salaries Of Pharmacists; 10.3.2. China Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 10.3.3. China Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 10.3.4. China Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 10.3.5. China Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020; 10.3.6. China Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020; 10.4. India Pharmaceutical Drugs And Biologics Market; 10.4.1. India Pharmaceutical Drugs And Biologics Market Overview; Average Salaries Of Pharmacists; 10.4.2. India Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 10.4.3. India Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 10.4.4. India Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 10.4.5. India Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020; 10.4.6. India Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020; 10.5. Japan Pharmaceutical Drugs And Biologics Market; 10.5.1. Japan Pharmaceutical Drugs And Biologics Market Overview; Average Salaries Of Pharmacists; 10.5.2. Japan Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 10.5.3. Japan Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 10.5.4. Japan Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 10.5.5. Japan Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020; 10.5.6. Japan Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020; 10.5.7. Japan Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 10.5.7.1. Japan Generic & Branded Sales Proportion By Country (Volume), 2012-2016; 10.5.7.2. Japan Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016; 10.6. Australia Pharmaceutical Drugs And Biologics Market; 10.6.1. Australia Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 10.6.2. Australia Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 10.6.3. Australia Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 10.6.4. Australia Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020; 10.6.5. Australia Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020;
11. Western Europe Pharmaceutical Drugs And Biologics Market;
11.1.1. Western Europe Pharmaceutical Drugs And Biologics Market Overview; 11.1.2. Western Europe Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 11.1.3. Western Europe Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 11.1.4. Western Europe Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 11.2. Western Europe Pharmaceutical Drugs And Biologics Market: Country Analysis; 11.3. UK Pharmaceutical Drugs And Biologics Market; 11.3.1. UK Pharmaceutical Drugs And Biologics Market Overview; Average Salaries Of Pharmacists; 11.3.2. UK Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 11.3.3. UK Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 11.3.4. UK Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 11.3.5. UK Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020; 11.3.6. UK Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020; 11.3.7. UK Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 11.3.7.1 UK Generic & Branded Sales Proportion By Country (Volume), 2012-2016; 11.3.7.2 UK Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016; 11.4. Germany Pharmaceutical Drugs And Biologics Market; 11.4.1. Germany Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 11.4.2. Germany Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 11.4.3. Germany Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 11.4.4 Germany Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020; 11.4.5 Germany Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020; 11.4.6 Germany Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 11.4.7.1 Germany Generic & Branded Sales Proportion By Country (Volume), 2012-2016; 11.4.7.2 Germany Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016; 11.5 France Pharmaceutical Drugs And Biologics Market; 11.5.1 France Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 11.5.2 France Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 11.5.3 France Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 11.5.4 France Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020; 11.5.5 France Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020; 11.5.6 France Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 11.5.6.1 France Generic & Branded Sales Proportion By Country (Volume), 2012-2016; 11.5.6.2 France Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016; 11.6. Italy Pharmaceutical Drugs And Biologics Market; 11.6. Italy Pharmaceutical Drugs And Biologics Market; 11.6.1. Italy Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 11.6.2. Italy Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 11.6.3. Italy Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 11.6.4. Italy Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020; 11.6.5. Italy Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020; 11.6.6. Italy Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 11.6.6.1 Italy Generic & Branded Sales Proportion By Country (Volume), 2012-2016; 11.6.6.2 Italy Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016; 11.7. Spain Pharmaceutical Drugs And Biologics Market; 11.7.1. Spain Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 11.7.2. Spain Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 11.7.3. Spain Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 11.7.4. Spain Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020; 11.7.5. Spain Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020; 11.7.6. Spain Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 11.7.6.1 Spain Generic & Branded Sales Proportion By Country (Volume), 2012-2016; 11.7.6.2 Spain Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016;
12. Eastern Europe Pharmaceutical Drugs And Biologics Market;
12.1.1. Eastern Europe Pharmaceutical Drugs And Biologics Market Overview; 12.1.2. Eastern Europe Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 12.1.3. Eastern Europe Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 12.1.4 Eastern Europe Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 12.2. Eastern Europe Pharmaceutical Drugs And Biologics Market: Country Analysis; 12.3. Russia Pharmaceutical Drugs And Biologics Market; 12.3.1. Russia Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 12.3.2. Russia Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 12.3.3. Russia Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 12.3.4. Russia Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020; 12.3.5. Russia Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020;
13. North America Pharmaceutical Drugs And Biologics Market;
13.1.1. North America Pharmaceutical Drugs And Biologics Market Overview; 13.1.2. North America Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 13.1.3. North America Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 13.1.4. North America Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 13.2. North America Pharmaceutical Drugs And Biologics Market: Country Analysis; 13.3. USA Pharmaceutical Drugs And Biologics Market; 13.3.1. USA Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 13.3.2. USA Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 13.3.3 USA Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 13.3.4. USA Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020; 13.3.5. USA Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020; 13.3.6. USA Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 13.3.6.1 USA Generic & Branded Sales Proportion By Country (Volume), 2012-2016; 13.3.6.2 USA Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016;
14. South America Pharmaceutical Drugs And Biologics Market;
14.1.1. South America Pharmaceutical Drugs And Biologics Market Overview; 14.1.2. South America Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 14.1.3. South America Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 14.1.4. South America Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 14.2. South America Pharmaceutical Drugs And Biologics Market: Country Analysis; 14.3. Brazil Pharmaceutical Drugs And Biologics Market; 14.3.1. Brazil Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 14.3.2. Brazil Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 14.3.3. Brazil Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 14.3.4. Brazil Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020; 14.3.5. Brazil Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020;
15. Middle East Pharmaceutical Drugs And Biologics Market;
15.1.1. Middle East Pharmaceutical Drugs And Biologics Market Overview; 15.1.2. Middle East Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 15.1.3. Middle East Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 15.1.4. Middle East Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs;
16. Africa Pharmaceutical Drugs And Biologics Market;
16.1.1. Africa Pharmaceutical Drugs And Biologics Market Overview; 16.1.2. Africa Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 16.1.3. Africa Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 16.1.4. Africa Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Pharmaceutical Drugs;
17. Pharmaceutical Drugs And Biologics Market Competitive Landscape;
17.1. Company Profiles; 17.2. Pfizer; 17.2.1. Overview; 17.2.2. Products And Services; 17.2.3. Strategy; 17.2.4. Financial Performance; 17.3. Roche; 17.3.1. Overview; 17.3.2. Products And Services; 17.3.3. Strategy; 17.3.4. Financial Performance; 17.4. Glaxosmithkline; 17.4.1. Overview; 17.4.2. Products And Services; 17.4.3. Strategy; 17.4.4. Financial Performance; 17.5. Merck & Co.; 17.5.1. Overview; 17.5.2. Products And Services; 17.5.3. Strategy; 17.5.4. Financial Performance; 17.6. Sanofi; 17.6.1. Overview; 17.6.2. Products And Services; 17.6.3. Strategy; 17.6.4. Financial Performance;
18. Key Mergers And Acquisitions In The Pharmaceutical Drugs And Biologics Market;
19. Market Background: Healthcare Market;
19.1.1. Healthcare Market Characteristics; 19.1.2. Healthcare Market Historic Growth; 19.1.2.1. Drivers Of The Market; 19.1.2.2. Restraints Of The Market; 19.1.3. Healthcare Market Forecast Growth; 19.1.3.1. Drivers Of The Market; 19.1.3.2. Restraints Of The Market; 19.1.4. Healthcare Trends And Strategies; 19.2. Healthcare Market Regional And Country Analysis; 19.2.1. Global Healthcare Market, 2016, By Region; 19.2.2. Global Healthcare Market, 2012-2020, Historic And Forecast, By Region; 19.2.3. Healthcare Market, 2016, By Country; 19.2.4. Healthcare Market, 2012-2020, Historic And Forecast, By Country; 19.2.5. Global Healthcare Market, Growth And Market Share Comparison, By Segment; 19.2.6. Global Healthcare Market, Growth And Market Share Comparison, By Country And Segment; 19.3. Global Healthcare Market Comparison With Macro Economic Factors; 19.3.1. Healthcare Market Size, Percentage Of GDP, Global; 19.3.2. Per Capita Average Healthcare Expenditure, Global; 19.4. Healthcare Market Comparison With Macro Economic Factors Across Countries; 19.4.1. Healthcare Market Size, Percentage Of GDP, By Country; 19.4.2. Per Capita Average Healthcare Expenditure, By Country; 19.5. Key Mergers And Acquisitions In The Healthcare Market;
20. Healthcare Industry Financial Margins;
21. Appendix;
21.1. NAICS Definitions Of Industry Covered In This Report; 21.2. Abbreviations; 21.3. Currencies; 21.4. Research Inquiries; 21.5. The Business Research Company; 21.6. Copyright And Disclaimer
List Of Figure
Table 1: Global Pharmaceutical Drugs And Biologics Historic Market Growth
Table 2: Global Pharmaceutical Drugs And Biologics Forecast Market Growth
Table 3: Pharmaceutical Drugs And Biologics Market Segmentation
Table 4: Global Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Table 5: Global Pharmaceutical Drugs And Biologics Market, 2012-2020, Historic And Forecast, By Segment
Table 6: Global Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2016
Table 7: Global Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2012-2020, Historic and Forecast
Table 8: Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2016, By Region
Table 9: Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2016, By Country
Table 10: Global Pharmaceutical Drugs Market, 2016, By Segment
Table 11: Global Pharmaceutical Drugs Market, 2012-2020, Historic and Forecast, By Segment
Table 12: Global Biologics Market, 2016, By Segment
Table 13: Global Biologics Market, 2012-2020, Historic and Forecast, By Segment
Table 14: Global Pharmaceutical Drugs And Biologics Market, 2016, By Region
Table 15: Global Pharmaceutical Drugs And Biologics Market, 2012-2020, Historic And Forecast, By Region
Table 16: Pharmaceutical Drugs And Biologics Market, 2016, By Country
Table 17: Pharmaceutical Drugs And Biologics Market, 2012-2020, Historic And Forecast, By Country
Table 18: Global Healthcare Market Segments, 2016, By Region
Table 19: Global Pharmaceutical Drugs And Biologics Market Segments, 2016, By Region
Table 20: Global Healthcare Market Segments, 2016, By Country
Table 21: Global Pharmaceutical Drugs And Biologics Market Segments, 2016, By Country
Table 22: Pharmaceutical Drugs And Biologics Market Size, Percentage Of GDP, Global
Table 23: Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, Global
Table 24: Pharmaceutical Drugs And Biologics Market Comparison With Macro Economic Factors Across Countries
Table 25: Pharmaceutical Drugs And Biologics Market Size, Percentage Of GDP, By Country
Table 26: Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, By Country
Table 27: Global Number Of Pharmacists, 2016, By Country
Table 28: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Pharmacists, 2016, By Country
Table 29: Global Average Salaries Of Pharmacists, 2016, By Country
Table 30: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Average Salaries Of Pharmacists, 2016, By Country
Table 31: Global Number Of Pharma Enterprises, 2016, By Country
Table 32: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country
Table 33: Global Number Of Employees In Pharmaceutical Industry, 2016, By Country
Table 34: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Employees In Pharmaceutical Industry, 2016, By Country
Table 35: Global Average Spending On R&D/Product Development, 2016, By Country
Table 36: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country
Table 37: Global Generic & Branded Sales Proportion By Country (Volume), 2016, By Country
Table 38: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2016, By Country
Table 39: Global Number Of Pharmacies, 2016, By Country
Table 40: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Pharmacies, 2016, By Country
Table 41: Global New Drug Approvals, 2016, By Country
Table 42: Global Pharmaceutical Drugs And Biologics Market Revenue Versus New Drug Approvals, 2016, By Country
Table 43: Global Number Of General Practitioners 2016, By Country
Table 44: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of General Practitioners, 2016, By Country
Table 45: Asia-Pacific Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Table 46: Asia-Pacific Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Table 47: Asia-Pacific Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Table 48: China Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Table 49: China Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Table 50: China Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Table 51: China Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Table 52: China Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Table 53: India Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Table 54: India Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Table 55: India Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Table 56: India Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Table 57: India Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Table 58: Japan Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Table 59: Japan Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Table 60: Japan Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Table 61: Japan Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Table 62: Japan Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Table 63: Japan Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Table 64: Japan Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Table 65: Australia Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Table 66: Australia Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Table 67: Australia Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Table 68: Australia Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Table 69: Australia Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Table 70: Western Europe Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Table 71: Western Europe Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Table 72: Western Europe Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Table 73: UK Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Table 74: UK Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Table 75: UK Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Table 76: UK Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Table 77: UK Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Table 78: UK Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Table 79: UK Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Table 80: Germany Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Table 81: Germany Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Table 82: Germany Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Table 83: Germany Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Table 84: Germany Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Table 85: Germany Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Table 86: Germany Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Table 87: France Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Table 88: France Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Table 89: France Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Table 90: France Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Table 91: France Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Table 92: France Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Table 93: France Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Table 94: Italy Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Table 95: Italy Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Table 96: Italy Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Table 97: Italy Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Table 98: Italy Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Table 99: Italy Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Table 100: Italy Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Table 101: Spain Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Table 102: Spain Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Table 103: Spain Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Table 104: Spain Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Table 105: Spain Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Table 106: Spain Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Table 107: Spain Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Table 108: Eastern Europe Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Table 109: Eastern Europe Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Table 110: Eastern Europe Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Table 111: Russia Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Table 112: Russia Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Table 113: Russia Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Table 114: Russia Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Table 115: Russia Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Table 116: North America Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Table 117: North America Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Table 118: North America Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Table 119: USA Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Table 120: USA Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Table 121: USA Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Table 122: USA Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Table 123: USA Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Table 124: USA Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Table 125: USA Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Table 126: South America Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Table 127: South America Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Table 128: South America Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Table 129: Brazil Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Table 130: Brazil Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Table 131: Brazil Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Table 132: Brazil Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Table 133: Brazil Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Table 134: Middle East Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Table 135: Middle East Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Table 136: Middle East Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Table 137: Africa Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Table 138: Africa Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Table 139: Africa Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Table 140: Pfizer Financial Performance
Table 141: Roche Financial Performance
Table 142: Glaxosmithkline Financial Performance
Table 143: Merck & Co. Financial Performance
Table 144: Sanofi Financial Performance
Table 145: Healthcare Market Historic Growth
Table 146: Healthcare Market Forecast Growth
Table 147: Global Healthcare Market, 2016, By Region
Table 148: Global Healthcare Market, 2012-2020, Historic And Forecast, By Region
Table 149: Healthcare Market, 2016, By Country
Table 150: Healthcare Market, 2012-2020, Historic And Forecast, By Country
Table 151: Global Healthcare Market, Growth And Market Share Comparison, By Segment
Table 152: Global Healthcare Market, Growth And Market Share Comparison, By Country And Segment
Table 153: Healthcare Market Size, Percentage Of GDP, Global
Table 154: Per Capita Average Healthcare Expenditure, Global
Table 155: Healthcare Market Comparison With Macro Economic Factors Across Countries
Table 156: Healthcare Market Size, Percentage Of GDP, By Country
Table 157: Per Capita Average Healthcare Expenditure, By Country
Table 158: Healthcare Industry Financial Margins
List Of Table
Figure 1: Global Pharmaceutical Drugs And Biologics Historic Market Growth
Figure 2: Global Pharmaceutical Drugs And Biologics Forecast Market Growth
Figure 3: Pharmaceutical Drugs And Biologics Market Segmentation
Figure 4: Global Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Figure 5: Global Pharmaceutical Drugs And Biologics Market, 2012-2020, Historic And Forecast, By Segment
Figure 6: Global Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2016
Figure 7: Global Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2012-2020, Historic and Forecast
Figure 8: Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2016, By Region
Figure 9: Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2016, By Country
Figure 10: Global Pharmaceutical Drugs Market, 2016, By Segment
Figure 11: Global Pharmaceutical Drugs Market, 2012-2020, Historic and Forecast, By Segment
Figure 12: Global Biologics Market, 2016, By Segment
Figure 13: Global Biologics Market, 2012-2020, Historic and Forecast, By Segment
Figure 14: Global Pharmaceutical Drugs And Biologics Market, 2016, By Region
Figure 15: Global Pharmaceutical Drugs And Biologics Market, 2012-2020, Historic And Forecast, By Region
Figure 16: Pharmaceutical Drugs And Biologics Market, 2016, By Country
Figure 17: Pharmaceutical Drugs And Biologics Market, 2012-2020, Historic And Forecast, By Country
Figure 18: Global Healthcare Market Segments, 2016, By Region
Figure 19: Global Pharmaceutical Drugs And Biologics Market Segments, 2016, By Region
Figure 20: Global Healthcare Market Segments, 2016, By Country
Figure 21: Global Pharmaceutical Drugs And Biologics Market Segments, 2016, By Country
Figure 22: Pharmaceutical Drugs And Biologics Market Size, Percentage Of GDP, Global
Figure 23: Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, Global
Figure 24: Pharmaceutical Drugs And Biologics Market Comparison With Macro Economic Factors Across Countries
Figure 25: Pharmaceutical Drugs And Biologics Market Size, Percentage Of GDP, By Country
Figure 26: Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, By Country
Figure 27: Global Number Of Pharmacists, 2016, By Country
Figure 28: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Pharmacists, 2016, By Country
Figure 29: Global Average Salaries Of Pharmacists, 2016, By Country
Figure 30: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Average Salaries Of Pharmacists, 2016, By Country
Figure 31: Global Number Of Pharma Enterprises, 2016, By Country
Figure 32: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country
Figure 33: Global Number Of Employees In Pharmaceutical Industry, 2016, By Country
Figure 34: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Employees In Pharmaceutical Industry, 2016, By Country
Figure 35: Global Average Spending On R&D/Product Development, 2016, By Country
Figure 36: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country
Figure 37: Global Generic & Branded Sales Proportion By Country (Volume), 2016, By Country
Figure 38: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2016, By Country
Figure 39: Global Number Of Pharmacies, 2016, By Country
Figure 40: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Pharmacies, 2016, By Country
Figure 41: Global New Drug Approvals, 2016, By Country
Figure 42: Global Pharmaceutical Drugs And Biologics Market Revenue Versus New Drug Approvals, 2016, By Country
Figure 43: Global Number Of General Practitioners 2016, By Country
Figure 44: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of General Practitioners, 2016, By Country
Figure 45: Asia-Pacific Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Figure 46: Asia-Pacific Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Figure 47: Asia-Pacific Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Figure 48: China Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Figure 49: China Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Figure 50: China Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Figure 51: China Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Figure 52: China Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Figure 53: India Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Figure 54: India Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Figure 55: India Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Figure 56: India Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Figure 57: India Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Figure 58: Japan Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Figure 59: Japan Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Figure 60: Japan Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Figure 61: Japan Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Figure 62: Japan Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Figure 63: Japan Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Figure 64: Japan Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Figure 65: Australia Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Figure 66: Australia Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Figure 67: Australia Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Figure 68: Australia Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Figure 69: Australia Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Figure 70: Western Europe Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Figure 71: Western Europe Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Figure 72: Western Europe Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Figure 73: UK Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Figure 74: UK Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Figure 75: UK Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Figure 76: UK Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Figure 77: UK Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Figure 78: UK Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Figure 79: UK Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Figure 80: Germany Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Figure 81: Germany Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Figure 82: Germany Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Figure 83: Germany Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Figure 84: Germany Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Figure 85: Germany Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Figure 86: Germany Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Figure 87: France Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Figure 88: France Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Figure 89: France Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Figure 90: France Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Figure 91: France Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Figure 92: France Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Figure 93: France Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Figure 94: Italy Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Figure 95: Italy Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Figure 96: Italy Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Figure 97: Italy Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Figure 98: Italy Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Figure 99: Italy Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Figure 100: Italy Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Figure 101: Spain Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Figure 102: Spain Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Figure 103: Spain Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Figure 104: Spain Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Figure 105: Spain Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Figure 106: Spain Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Figure 107: Spain Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Figure 108: Eastern Europe Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Figure 109: Eastern Europe Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Figure 110: Eastern Europe Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Figure 111: Russia Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Figure 112: Russia Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Figure 113: Russia Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Figure 114: Russia Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Figure 115: Russia Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Figure 116: North America Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Figure 117: North America Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Figure 118: North America Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Figure 119: USA Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Figure 120: USA Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Figure 121: USA Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Figure 122: USA Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Figure 123: USA Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Figure 124: USA Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Figure 125: USA Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Figure 126: South America Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Figure 127: South America Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Figure 128: South America Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Figure 129: Brazil Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Figure 130: Brazil Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Figure 131: Brazil Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Figure 132: Brazil Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Figure 133: Brazil Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Figure 134: Middle East Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Figure 135: Middle East Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Figure 136: Middle East Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Figure 137: Africa Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Figure 138: Africa Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Figure 139: Africa Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Figure 140: Pfizer Financial Performance
Figure 141: Roche Financial Performance
Figure 142: Glaxosmithkline Financial Performance
Figure 143: Merck & Co. Financial Performance
Figure 144: Sanofi Financial Performance
Figure 145: Healthcare Market Historic Growth
Figure 146: Healthcare Market Forecast Growth
Figure 147: Global Healthcare Market, 2016, By Region
Figure 148: Global Healthcare Market, 2012-2020, Historic And Forecast, By Region
Figure 149: Healthcare Market, 2016, By Country
Figure 150: Healthcare Market, 2012-2020, Historic And Forecast, By Country
Figure 151: Global Healthcare Market, Growth And Market Share Comparison, By Segment
Figure 152: Global Healthcare Market, Growth And Market Share Comparison, By Country And Segment
Figure 153: Healthcare Market Size, Percentage Of GDP, Global
Figure 154: Per Capita Average Healthcare Expenditure, Global
Figure 155: Healthcare Market Comparison With Macro Economic Factors Across Countries
Figure 156: Healthcare Market Size, Percentage Of GDP, By Country
Figure 157: Per Capita Average Healthcare Expenditure, By Country
Figure 158: Healthcare Industry Financial Margins
Licence Rights
- Single User License (for access by one person)
- Site License (for access of one office location of a company)
- Corporate License (allow access by all staff of the company)
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Products
Biologics, Pharmaceutical Drugs
Companies
Pfizer, Roche, Glaxosmithkline, Merck & Co., and Sanofi
Company Profile
Company Profile Title
The pharmaceuticals industry develops drugs to diagnose, cure, treat or prevent diseases. Pharmaceutical companies produce both generic and branded drugs for medications. Pharmaceuticals are subjected to various laws and regulations that deal with patenting, testing, safety, efficacy and marketing of drugs.
Pharmaceutical companies produce biological products, pharmaceutical preparations and medicinal and botanical products.
The global pharmaceutical market is expected to reach over $1300 billion in 2020. one of the key drivers of the pharmaceuticals market during 2016-2020 is expected to include 'New Methods For Drug Discovery'. Stem cells and organ on chip technologies are changing the way drug trials are being conducted. Organ on chips are micro-engineered biometric systems that simulates activities, mechanics and physiological response of organ systems. Drug trial processes such as target identification, validation, target based screening and phenotypic screening are being done through organ on chip and stem cell technologies. These technologies are considerably reducing the drug discovery costs and generating reliable predictions on drug efficiency and human safety. Therefore, low drug discovery costs and accurate results generated from these technologies is expected to drive the pharmaceuticals market.
The Americas was the largest region in the pharmaceutical market in 2016, accounting for around 45% market share. Asia was the second largest region accounting for around 27% market share. Europe was the third largest region accounting for around 22% market share.
One of the top trends that is observed in the pharmaceuticals market include 'Turning Away From Animal Testing'. The pharmaceutical industry is moving away from animal testing towards cheaper and more efficient technologies. For example, LiverChip technology created an alternative model of testing which uses a 3D cell culture platform that mimics the architecture and physiology of a human being, which was significantly less expensive and more efficient than animal testing.
The Pharmaceutical Drugs And Biologics Market Global Report provides strategists, marketers and senior management with the critical information they need to assess the global pharmaceutical drugs and biologics sector.
Reasons to Purchase
Outperform competitors using accurate up to date demand-side dynamics information.
Identify growth segments for investment.
Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
Create regional and country strategies on the basis of local data and analysis.
Stay abreast of the latest customer and market research findings
Benchmark performance against key competitors.
Develop strategies based on likely future developments.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Gain a global perspective on the development of the market.
Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:
Where is the largest and fastest growing market for the pharmaceutical drugs and biologics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical drugs and biologics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider healthcare market, and compares it with other markets.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
Market segmentations break down market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
The pharmaceutical drugs and biologics market section of the report gives context. It compares the pharmaceutical drugs and biologics market with other segments of the healthcare market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Pharmaceutical Drugs And Biologics Indicators Comparison.
The industry metrics section looks at critical drivers including patient numbers (epidemiology) hospital beds and specialist physicians while the macro-economic section looks at the market in relation to the overall economy.
Scope
Markets Covered: Pharmaceuticals, Biologics, Pharmaceutical Drugs
Companies Mentioned: Pfizer, Roche, Glaxosmithkline, Merck & Co., and Sanofi
Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.
Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa
Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Pharmaceutical Drugs And Biologics Indicators Comparison.
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Scope
1. Pharmaceutical Drugs And Biologics Market Characteristics;
2. Pharmaceutical Drugs And Biologics Market Size And Growth;
2.1. Historic Market Growth; 2.1.1. Drivers Of The Market; Aging Populations; Emerging Markets Growth; Health Insurance Reforms; 2.1.2. Restraints On The Market; Patent Expiration Of Drugs; Pricing Pressures From Regulators; High Costs Of Drug Approval; 2.2. Forecast Market Growth; 2.2.1. Drivers Of The Market; Economic Growth; Technology; Changes In Lifestyles; New Methods For Drug Discovery; 2.2.2. Restraints On The Market; Cost; Interest Rate Increases; Reduction In Free Trade;
3. Pestle Analysis;
3.1. Political; 3.2. Economic; 3.3. Social; 3.4. Technological; 3.5. Legal; 3.6. Environmental;
4. Pharmaceutical Drugs And Biologics Market Customer Information;
5. Pharmaceutical Drugs And Biologics Market Segmentation;
5.1. Global Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 5.2. Global Pharmaceutical Drugs And Biologics Market, 2012-2020, Historic And Forecast, By Segment; 5.3 Global Pharmaceutical Drugs And Biologics Market Trends And Strategies; Turning Away From Animal Testing; Increase In Personalized Medicine; Collaboration Driving Innovation; Increase In Mergers And Acquisitions; Rise Of Biologics/Gene Therapy; Aggressive Pricing Changes In Some Drugs; 5.4 Global Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2016; 5.5 Global Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2012-2020, Historic and Forecast; 5.6 Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2016, By Region; 5.7 Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2016, By Country; 5.8 Pharmaceutical Drugs; 5.8.1. Market Characteristics; 5.8.2. Global Pharmaceutical Drugs Market, 2016, By Segment; 5.8.3. Global Pharmaceutical Drugs Market, 2012-2020, Historic and Forecast, By Segment; 5.8.4. Market Trends And Strategies; 5.9 Biologics; 5.9.1. Market Characteristics; 5.9.2. Global Biologics Market, 2016, By Segment; 5.9.3. Global Biologics Market, 2012-2020, Historic and Forecast, By Segment; 5.9.4. Market Trends And Strategies;
6. Pharmaceutical Drugs And Biologics Market Regional And Country Analysis;
6.1. Global Pharmaceutical Drugs And Biologics Market, 2016, By Region; 6.2. Global Pharmaceutical Drugs And Biologics Market, 2012-2020, Historic And Forecast, By Region; 6.3. Pharmaceutical Drugs And Biologics Market, 2016, By Country; 6.4. Pharmaceutical Drugs And Biologics Market, 2012-2020, Historic And Forecast, By Country; 6.5. Global Healthcare Market Segments, 2016, By Region; 6.6. Global Pharmaceutical Drugs And Biologics Market Segments, 2016, By Region; 6.7. Global Healthcare Market Segments, 2016, By Country; 6.8. Global Pharmaceutical Drugs And Biologics Market Segments, 2016, By Country;
7. Global Pharmaceutical Drugs And Biologics Market Comparison With Macro Economic Factors;
7.1. Pharmaceutical Drugs And Biologics Market Size, Percentage Of GDP, Global; 7.2. Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, Global;
8. Pharmaceutical Drugs And Biologics Market Comparison With Macro Economic Factors Across Countries;
8.1. Pharmaceutical Drugs And Biologics Market Size, Percentage Of GDP, By Country; 8.2. Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, By Country;
9. Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics;
9.1. Global Number Of Pharmacists, 2016, By Country; 9.2. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Pharmacists, 2016, By Country; 9.3. Global Number Of Pharma Enterprises, 2016, By Country; 9.4. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country; 9.5. Global Number Of Employees In Pharmaceutical Industry, 2016, By Country; 9.6. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Employees In Pharmaceutical Industry, 2016, By Country; 9.7. Global Average Spending On R&D/Product Development, 2016, By Country; 9.8. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country; 9.9. Global Generic & Branded Sales Proportion By Country (Volume), 2016, By Country; 9.10. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2016, By Country; 9.11. Global Number Of Pharmacies, 2016, By Country; 9.12. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Pharmacies, 2016, By Country; 9.13. Global New Drug Approvals, 2016, By Country; 9.14. Global Pharmaceutical Drugs And Biologics Market Revenue Versus New Drug Approvals, 2016, By Country; 9.15. Global Number Of General Practitioners 2016, By Country; 9.16. Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of General Practitioners, 2016, By Country;
10. Asia-Pacific Pharmaceutical Drugs And Biologics Market;
10.1.1. Asia-Pacific Pharmaceutical Drugs And Biologics Market Overview; 10.1.2. Asia-Pacific Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 10.1.3. Asia-Pacific Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 10.1.4. Asia-Pacific Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 10.2. Asia-Pacific Pharmaceutical Drugs And Biologics Market: Country Analysis; 10.3. China Pharmaceutical Drugs And Biologics Market; 10.3.1. China Pharmaceutical Drugs And Biologics Market Overview; Average Salaries Of Pharmacists; 10.3.2. China Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 10.3.3. China Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 10.3.4. China Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 10.3.5. China Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020; 10.3.6. China Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020; 10.4. India Pharmaceutical Drugs And Biologics Market; 10.4.1. India Pharmaceutical Drugs And Biologics Market Overview; Average Salaries Of Pharmacists; 10.4.2. India Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 10.4.3. India Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 10.4.4. India Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 10.4.5. India Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020; 10.4.6. India Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020; 10.5. Japan Pharmaceutical Drugs And Biologics Market; 10.5.1. Japan Pharmaceutical Drugs And Biologics Market Overview; Average Salaries Of Pharmacists; 10.5.2. Japan Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 10.5.3. Japan Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 10.5.4. Japan Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 10.5.5. Japan Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020; 10.5.6. Japan Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020; 10.5.7. Japan Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 10.5.7.1. Japan Generic & Branded Sales Proportion By Country (Volume), 2012-2016; 10.5.7.2. Japan Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016; 10.6. Australia Pharmaceutical Drugs And Biologics Market; 10.6.1. Australia Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 10.6.2. Australia Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 10.6.3. Australia Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 10.6.4. Australia Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020; 10.6.5. Australia Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020;
11. Western Europe Pharmaceutical Drugs And Biologics Market;
11.1.1. Western Europe Pharmaceutical Drugs And Biologics Market Overview; 11.1.2. Western Europe Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 11.1.3. Western Europe Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 11.1.4. Western Europe Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 11.2. Western Europe Pharmaceutical Drugs And Biologics Market: Country Analysis; 11.3. UK Pharmaceutical Drugs And Biologics Market; 11.3.1. UK Pharmaceutical Drugs And Biologics Market Overview; Average Salaries Of Pharmacists; 11.3.2. UK Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 11.3.3. UK Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 11.3.4. UK Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 11.3.5. UK Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020; 11.3.6. UK Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020; 11.3.7. UK Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 11.3.7.1 UK Generic & Branded Sales Proportion By Country (Volume), 2012-2016; 11.3.7.2 UK Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016; 11.4. Germany Pharmaceutical Drugs And Biologics Market; 11.4.1. Germany Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 11.4.2. Germany Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 11.4.3. Germany Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 11.4.4 Germany Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020; 11.4.5 Germany Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020; 11.4.6 Germany Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 11.4.7.1 Germany Generic & Branded Sales Proportion By Country (Volume), 2012-2016; 11.4.7.2 Germany Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016; 11.5 France Pharmaceutical Drugs And Biologics Market; 11.5.1 France Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 11.5.2 France Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 11.5.3 France Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 11.5.4 France Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020; 11.5.5 France Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020; 11.5.6 France Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 11.5.6.1 France Generic & Branded Sales Proportion By Country (Volume), 2012-2016; 11.5.6.2 France Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016; 11.6. Italy Pharmaceutical Drugs And Biologics Market; 11.6. Italy Pharmaceutical Drugs And Biologics Market; 11.6.1. Italy Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 11.6.2. Italy Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 11.6.3. Italy Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 11.6.4. Italy Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020; 11.6.5. Italy Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020; 11.6.6. Italy Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 11.6.6.1 Italy Generic & Branded Sales Proportion By Country (Volume), 2012-2016; 11.6.6.2 Italy Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016; 11.7. Spain Pharmaceutical Drugs And Biologics Market; 11.7.1. Spain Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 11.7.2. Spain Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 11.7.3. Spain Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 11.7.4. Spain Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020; 11.7.5. Spain Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020; 11.7.6. Spain Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 11.7.6.1 Spain Generic & Branded Sales Proportion By Country (Volume), 2012-2016; 11.7.6.2 Spain Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016;
12. Eastern Europe Pharmaceutical Drugs And Biologics Market;
12.1.1. Eastern Europe Pharmaceutical Drugs And Biologics Market Overview; 12.1.2. Eastern Europe Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 12.1.3. Eastern Europe Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 12.1.4 Eastern Europe Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 12.2. Eastern Europe Pharmaceutical Drugs And Biologics Market: Country Analysis; 12.3. Russia Pharmaceutical Drugs And Biologics Market; 12.3.1. Russia Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 12.3.2. Russia Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 12.3.3. Russia Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 12.3.4. Russia Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020; 12.3.5. Russia Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020;
13. North America Pharmaceutical Drugs And Biologics Market;
13.1.1. North America Pharmaceutical Drugs And Biologics Market Overview; 13.1.2. North America Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 13.1.3. North America Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 13.1.4. North America Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 13.2. North America Pharmaceutical Drugs And Biologics Market: Country Analysis; 13.3. USA Pharmaceutical Drugs And Biologics Market; 13.3.1. USA Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 13.3.2. USA Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 13.3.3 USA Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 13.3.4. USA Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020; 13.3.5. USA Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020; 13.3.6. USA Pharmaceutical Drugs And Biologics Market Comparison With Industry Metrics; 13.3.6.1 USA Generic & Branded Sales Proportion By Country (Volume), 2012-2016; 13.3.6.2 USA Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016;
14. South America Pharmaceutical Drugs And Biologics Market;
14.1.1. South America Pharmaceutical Drugs And Biologics Market Overview; 14.1.2. South America Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 14.1.3. South America Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 14.1.4. South America Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 14.2. South America Pharmaceutical Drugs And Biologics Market: Country Analysis; 14.3. Brazil Pharmaceutical Drugs And Biologics Market; 14.3.1. Brazil Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 14.3.2. Brazil Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 14.3.3. Brazil Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs; 14.3.4. Brazil Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020; 14.3.5. Brazil Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020;
15. Middle East Pharmaceutical Drugs And Biologics Market;
15.1.1. Middle East Pharmaceutical Drugs And Biologics Market Overview; 15.1.2. Middle East Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 15.1.3. Middle East Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 15.1.4. Middle East Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Biologics; Pharmaceutical Drugs;
16. Africa Pharmaceutical Drugs And Biologics Market;
16.1.1. Africa Pharmaceutical Drugs And Biologics Market Overview; 16.1.2. Africa Pharmaceutical Drugs And Biologics Historic Market, 2012-2016; 16.1.3. Africa Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020; 16.1.4. Africa Pharmaceutical Drugs And Biologics Market, 2016, By Segment; Pharmaceutical Drugs;
17. Pharmaceutical Drugs And Biologics Market Competitive Landscape;
17.1. Company Profiles; 17.2. Pfizer; 17.2.1. Overview; 17.2.2. Products And Services; 17.2.3. Strategy; 17.2.4. Financial Performance; 17.3. Roche; 17.3.1. Overview; 17.3.2. Products And Services; 17.3.3. Strategy; 17.3.4. Financial Performance; 17.4. Glaxosmithkline; 17.4.1. Overview; 17.4.2. Products And Services; 17.4.3. Strategy; 17.4.4. Financial Performance; 17.5. Merck & Co.; 17.5.1. Overview; 17.5.2. Products And Services; 17.5.3. Strategy; 17.5.4. Financial Performance; 17.6. Sanofi; 17.6.1. Overview; 17.6.2. Products And Services; 17.6.3. Strategy; 17.6.4. Financial Performance;
18. Key Mergers And Acquisitions In The Pharmaceutical Drugs And Biologics Market;
19. Market Background: Healthcare Market;
19.1.1. Healthcare Market Characteristics; 19.1.2. Healthcare Market Historic Growth; 19.1.2.1. Drivers Of The Market; 19.1.2.2. Restraints Of The Market; 19.1.3. Healthcare Market Forecast Growth; 19.1.3.1. Drivers Of The Market; 19.1.3.2. Restraints Of The Market; 19.1.4. Healthcare Trends And Strategies; 19.2. Healthcare Market Regional And Country Analysis; 19.2.1. Global Healthcare Market, 2016, By Region; 19.2.2. Global Healthcare Market, 2012-2020, Historic And Forecast, By Region; 19.2.3. Healthcare Market, 2016, By Country; 19.2.4. Healthcare Market, 2012-2020, Historic And Forecast, By Country; 19.2.5. Global Healthcare Market, Growth And Market Share Comparison, By Segment; 19.2.6. Global Healthcare Market, Growth And Market Share Comparison, By Country And Segment; 19.3. Global Healthcare Market Comparison With Macro Economic Factors; 19.3.1. Healthcare Market Size, Percentage Of GDP, Global; 19.3.2. Per Capita Average Healthcare Expenditure, Global; 19.4. Healthcare Market Comparison With Macro Economic Factors Across Countries; 19.4.1. Healthcare Market Size, Percentage Of GDP, By Country; 19.4.2. Per Capita Average Healthcare Expenditure, By Country; 19.5. Key Mergers And Acquisitions In The Healthcare Market;
20. Healthcare Industry Financial Margins;
21. Appendix;
21.1. NAICS Definitions Of Industry Covered In This Report; 21.2. Abbreviations; 21.3. Currencies; 21.4. Research Inquiries; 21.5. The Business Research Company; 21.6. Copyright And Disclaimer
List Of Figure
Table 1: Global Pharmaceutical Drugs And Biologics Historic Market Growth
Table 2: Global Pharmaceutical Drugs And Biologics Forecast Market Growth
Table 3: Pharmaceutical Drugs And Biologics Market Segmentation
Table 4: Global Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Table 5: Global Pharmaceutical Drugs And Biologics Market, 2012-2020, Historic And Forecast, By Segment
Table 6: Global Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2016
Table 7: Global Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2012-2020, Historic and Forecast
Table 8: Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2016, By Region
Table 9: Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2016, By Country
Table 10: Global Pharmaceutical Drugs Market, 2016, By Segment
Table 11: Global Pharmaceutical Drugs Market, 2012-2020, Historic and Forecast, By Segment
Table 12: Global Biologics Market, 2016, By Segment
Table 13: Global Biologics Market, 2012-2020, Historic and Forecast, By Segment
Table 14: Global Pharmaceutical Drugs And Biologics Market, 2016, By Region
Table 15: Global Pharmaceutical Drugs And Biologics Market, 2012-2020, Historic And Forecast, By Region
Table 16: Pharmaceutical Drugs And Biologics Market, 2016, By Country
Table 17: Pharmaceutical Drugs And Biologics Market, 2012-2020, Historic And Forecast, By Country
Table 18: Global Healthcare Market Segments, 2016, By Region
Table 19: Global Pharmaceutical Drugs And Biologics Market Segments, 2016, By Region
Table 20: Global Healthcare Market Segments, 2016, By Country
Table 21: Global Pharmaceutical Drugs And Biologics Market Segments, 2016, By Country
Table 22: Pharmaceutical Drugs And Biologics Market Size, Percentage Of GDP, Global
Table 23: Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, Global
Table 24: Pharmaceutical Drugs And Biologics Market Comparison With Macro Economic Factors Across Countries
Table 25: Pharmaceutical Drugs And Biologics Market Size, Percentage Of GDP, By Country
Table 26: Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, By Country
Table 27: Global Number Of Pharmacists, 2016, By Country
Table 28: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Pharmacists, 2016, By Country
Table 29: Global Average Salaries Of Pharmacists, 2016, By Country
Table 30: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Average Salaries Of Pharmacists, 2016, By Country
Table 31: Global Number Of Pharma Enterprises, 2016, By Country
Table 32: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country
Table 33: Global Number Of Employees In Pharmaceutical Industry, 2016, By Country
Table 34: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Employees In Pharmaceutical Industry, 2016, By Country
Table 35: Global Average Spending On R&D/Product Development, 2016, By Country
Table 36: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country
Table 37: Global Generic & Branded Sales Proportion By Country (Volume), 2016, By Country
Table 38: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2016, By Country
Table 39: Global Number Of Pharmacies, 2016, By Country
Table 40: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Pharmacies, 2016, By Country
Table 41: Global New Drug Approvals, 2016, By Country
Table 42: Global Pharmaceutical Drugs And Biologics Market Revenue Versus New Drug Approvals, 2016, By Country
Table 43: Global Number Of General Practitioners 2016, By Country
Table 44: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of General Practitioners, 2016, By Country
Table 45: Asia-Pacific Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Table 46: Asia-Pacific Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Table 47: Asia-Pacific Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Table 48: China Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Table 49: China Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Table 50: China Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Table 51: China Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Table 52: China Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Table 53: India Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Table 54: India Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Table 55: India Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Table 56: India Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Table 57: India Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Table 58: Japan Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Table 59: Japan Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Table 60: Japan Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Table 61: Japan Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Table 62: Japan Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Table 63: Japan Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Table 64: Japan Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Table 65: Australia Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Table 66: Australia Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Table 67: Australia Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Table 68: Australia Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Table 69: Australia Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Table 70: Western Europe Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Table 71: Western Europe Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Table 72: Western Europe Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Table 73: UK Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Table 74: UK Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Table 75: UK Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Table 76: UK Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Table 77: UK Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Table 78: UK Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Table 79: UK Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Table 80: Germany Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Table 81: Germany Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Table 82: Germany Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Table 83: Germany Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Table 84: Germany Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Table 85: Germany Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Table 86: Germany Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Table 87: France Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Table 88: France Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Table 89: France Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Table 90: France Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Table 91: France Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Table 92: France Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Table 93: France Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Table 94: Italy Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Table 95: Italy Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Table 96: Italy Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Table 97: Italy Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Table 98: Italy Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Table 99: Italy Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Table 100: Italy Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Table 101: Spain Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Table 102: Spain Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Table 103: Spain Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Table 104: Spain Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Table 105: Spain Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Table 106: Spain Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Table 107: Spain Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Table 108: Eastern Europe Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Table 109: Eastern Europe Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Table 110: Eastern Europe Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Table 111: Russia Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Table 112: Russia Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Table 113: Russia Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Table 114: Russia Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Table 115: Russia Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Table 116: North America Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Table 117: North America Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Table 118: North America Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Table 119: USA Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Table 120: USA Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Table 121: USA Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Table 122: USA Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Table 123: USA Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Table 124: USA Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Table 125: USA Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Table 126: South America Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Table 127: South America Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Table 128: South America Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Table 129: Brazil Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Table 130: Brazil Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Table 131: Brazil Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Table 132: Brazil Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Table 133: Brazil Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Table 134: Middle East Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Table 135: Middle East Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Table 136: Middle East Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Table 137: Africa Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Table 138: Africa Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Table 139: Africa Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Table 140: Pfizer Financial Performance
Table 141: Roche Financial Performance
Table 142: Glaxosmithkline Financial Performance
Table 143: Merck & Co. Financial Performance
Table 144: Sanofi Financial Performance
Table 145: Healthcare Market Historic Growth
Table 146: Healthcare Market Forecast Growth
Table 147: Global Healthcare Market, 2016, By Region
Table 148: Global Healthcare Market, 2012-2020, Historic And Forecast, By Region
Table 149: Healthcare Market, 2016, By Country
Table 150: Healthcare Market, 2012-2020, Historic And Forecast, By Country
Table 151: Global Healthcare Market, Growth And Market Share Comparison, By Segment
Table 152: Global Healthcare Market, Growth And Market Share Comparison, By Country And Segment
Table 153: Healthcare Market Size, Percentage Of GDP, Global
Table 154: Per Capita Average Healthcare Expenditure, Global
Table 155: Healthcare Market Comparison With Macro Economic Factors Across Countries
Table 156: Healthcare Market Size, Percentage Of GDP, By Country
Table 157: Per Capita Average Healthcare Expenditure, By Country
Table 158: Healthcare Industry Financial Margins
List Of Table
Figure 1: Global Pharmaceutical Drugs And Biologics Historic Market Growth
Figure 2: Global Pharmaceutical Drugs And Biologics Forecast Market Growth
Figure 3: Pharmaceutical Drugs And Biologics Market Segmentation
Figure 4: Global Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Figure 5: Global Pharmaceutical Drugs And Biologics Market, 2012-2020, Historic And Forecast, By Segment
Figure 6: Global Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2016
Figure 7: Global Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2012-2020, Historic and Forecast
Figure 8: Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2016, By Region
Figure 9: Pharmaceutical Drugs And Biologics Market Compared With Similar Markets, 2016, By Country
Figure 10: Global Pharmaceutical Drugs Market, 2016, By Segment
Figure 11: Global Pharmaceutical Drugs Market, 2012-2020, Historic and Forecast, By Segment
Figure 12: Global Biologics Market, 2016, By Segment
Figure 13: Global Biologics Market, 2012-2020, Historic and Forecast, By Segment
Figure 14: Global Pharmaceutical Drugs And Biologics Market, 2016, By Region
Figure 15: Global Pharmaceutical Drugs And Biologics Market, 2012-2020, Historic And Forecast, By Region
Figure 16: Pharmaceutical Drugs And Biologics Market, 2016, By Country
Figure 17: Pharmaceutical Drugs And Biologics Market, 2012-2020, Historic And Forecast, By Country
Figure 18: Global Healthcare Market Segments, 2016, By Region
Figure 19: Global Pharmaceutical Drugs And Biologics Market Segments, 2016, By Region
Figure 20: Global Healthcare Market Segments, 2016, By Country
Figure 21: Global Pharmaceutical Drugs And Biologics Market Segments, 2016, By Country
Figure 22: Pharmaceutical Drugs And Biologics Market Size, Percentage Of GDP, Global
Figure 23: Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, Global
Figure 24: Pharmaceutical Drugs And Biologics Market Comparison With Macro Economic Factors Across Countries
Figure 25: Pharmaceutical Drugs And Biologics Market Size, Percentage Of GDP, By Country
Figure 26: Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, By Country
Figure 27: Global Number Of Pharmacists, 2016, By Country
Figure 28: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Pharmacists, 2016, By Country
Figure 29: Global Average Salaries Of Pharmacists, 2016, By Country
Figure 30: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Average Salaries Of Pharmacists, 2016, By Country
Figure 31: Global Number Of Pharma Enterprises, 2016, By Country
Figure 32: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country
Figure 33: Global Number Of Employees In Pharmaceutical Industry, 2016, By Country
Figure 34: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Employees In Pharmaceutical Industry, 2016, By Country
Figure 35: Global Average Spending On R&D/Product Development, 2016, By Country
Figure 36: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country
Figure 37: Global Generic & Branded Sales Proportion By Country (Volume), 2016, By Country
Figure 38: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2016, By Country
Figure 39: Global Number Of Pharmacies, 2016, By Country
Figure 40: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of Pharmacies, 2016, By Country
Figure 41: Global New Drug Approvals, 2016, By Country
Figure 42: Global Pharmaceutical Drugs And Biologics Market Revenue Versus New Drug Approvals, 2016, By Country
Figure 43: Global Number Of General Practitioners 2016, By Country
Figure 44: Global Pharmaceutical Drugs And Biologics Market Revenue Versus Number Of General Practitioners, 2016, By Country
Figure 45: Asia-Pacific Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Figure 46: Asia-Pacific Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Figure 47: Asia-Pacific Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Figure 48: China Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Figure 49: China Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Figure 50: China Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Figure 51: China Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Figure 52: China Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Figure 53: India Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Figure 54: India Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Figure 55: India Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Figure 56: India Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Figure 57: India Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Figure 58: Japan Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Figure 59: Japan Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Figure 60: Japan Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Figure 61: Japan Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Figure 62: Japan Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Figure 63: Japan Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Figure 64: Japan Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Figure 65: Australia Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Figure 66: Australia Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Figure 67: Australia Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Figure 68: Australia Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Figure 69: Australia Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Figure 70: Western Europe Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Figure 71: Western Europe Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Figure 72: Western Europe Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Figure 73: UK Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Figure 74: UK Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Figure 75: UK Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Figure 76: UK Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Figure 77: UK Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Figure 78: UK Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Figure 79: UK Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Figure 80: Germany Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Figure 81: Germany Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Figure 82: Germany Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Figure 83: Germany Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Figure 84: Germany Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Figure 85: Germany Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Figure 86: Germany Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Figure 87: France Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Figure 88: France Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Figure 89: France Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Figure 90: France Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Figure 91: France Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Figure 92: France Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Figure 93: France Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Figure 94: Italy Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Figure 95: Italy Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Figure 96: Italy Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Figure 97: Italy Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Figure 98: Italy Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Figure 99: Italy Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Figure 100: Italy Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Figure 101: Spain Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Figure 102: Spain Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Figure 103: Spain Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Figure 104: Spain Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Figure 105: Spain Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Figure 106: Spain Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Figure 107: Spain Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Figure 108: Eastern Europe Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Figure 109: Eastern Europe Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Figure 110: Eastern Europe Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Figure 111: Russia Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Figure 112: Russia Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Figure 113: Russia Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Figure 114: Russia Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Figure 115: Russia Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Figure 116: North America Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Figure 117: North America Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Figure 118: North America Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Figure 119: USA Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Figure 120: USA Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Figure 121: USA Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Figure 122: USA Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Figure 123: USA Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Figure 124: USA Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Figure 125: USA Pharmaceutical Drugs And Biologics Market Revenue Versus Generic & Branded Sales Proportion By Country (Volume), 2012-2016
Figure 126: South America Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Figure 127: South America Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Figure 128: South America Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Figure 129: Brazil Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Figure 130: Brazil Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Figure 131: Brazil Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Figure 132: Brazil Pharmaceutical Drugs And Biologics Percentage Of GDP, 2012-2020
Figure 133: Brazil Per Capita Average Pharmaceutical Drugs And Biologics Expenditure, 2012-2020
Figure 134: Middle East Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Figure 135: Middle East Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Figure 136: Middle East Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Figure 137: Africa Pharmaceutical Drugs And Biologics Historic Market, 2012-2016
Figure 138: Africa Pharmaceutical Drugs And Biologics Forecast Market, 2016-2020
Figure 139: Africa Pharmaceutical Drugs And Biologics Market, 2016, By Segment
Figure 140: Pfizer Financial Performance
Figure 141: Roche Financial Performance
Figure 142: Glaxosmithkline Financial Performance
Figure 143: Merck & Co. Financial Performance
Figure 144: Sanofi Financial Performance
Figure 145: Healthcare Market Historic Growth
Figure 146: Healthcare Market Forecast Growth
Figure 147: Global Healthcare Market, 2016, By Region
Figure 148: Global Healthcare Market, 2012-2020, Historic And Forecast, By Region
Figure 149: Healthcare Market, 2016, By Country
Figure 150: Healthcare Market, 2012-2020, Historic And Forecast, By Country
Figure 151: Global Healthcare Market, Growth And Market Share Comparison, By Segment
Figure 152: Global Healthcare Market, Growth And Market Share Comparison, By Country And Segment
Figure 153: Healthcare Market Size, Percentage Of GDP, Global
Figure 154: Per Capita Average Healthcare Expenditure, Global
Figure 155: Healthcare Market Comparison With Macro Economic Factors Across Countries
Figure 156: Healthcare Market Size, Percentage Of GDP, By Country
Figure 157: Per Capita Average Healthcare Expenditure, By Country
Figure 158: Healthcare Industry Financial Margins
- Single User License (for access by one person)
- Site License (for access of one office location of a company)
- Corporate License (allow access by all staff of the company)
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products
Biologics, Pharmaceutical Drugs
Companies
Pfizer, Roche, Glaxosmithkline, Merck & Co., and Sanofi